PATENT CLAIM ANALYSIS

Application Number: 16033169
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "275000"]

Abstract:
The applicaton discloses pharmaceutical compounds of formula I useful for treating CNS diseases wherein m, s, R 1 R 5 , R 6  and R 7  are as defined herein.

Claim (Index 5):
The method of  claim 3 , wherein the central nervous system disease state is a memory disorder.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14531465', '11985459', '11315706', '12694033', '11820712']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7722762952486613
- 35 USC 102 Novelty (BERT): 0.53218473503252
- Combined Prediction Score: 0.7482671392270472
- Mean Citation Score: 293.9038280000001
- Max Citation Score: 305.55164
- Similarity Product: 172.27040836729049

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test